ESR1 and breast carcinoma: In the present study we used additional CDK9i AT7519 [19] and BE-09-LN53 [21], and confirmed that these have similar effects on MYB transcription, and also selectively induce apoptosis in ER+ve/MYB+ve breast cancer cells.